EmUprichard

Social Scientist. Complexity. Methodologist. Former Alan Turing Fellow. Breathworker -

[EmUprichard @EmUprichard]

I got Covid in early March 2020 and it changed my life. But then I found breathwork and it changed my life even more! In August, I'm going to post about the power of the breath and breathwork and some of the things I've learned. The breath is the gift that keeps giving!

[EmUprichard @EmUprichard]

@fakemillanp I agree! Thanks for this tool.

[Kirsty Schnickelfritz @KSchnickelfritz]

Stop judging people with chronic illnesses by how you think they should look or behave. Dr Amir Khan once again hits the nail on the head. #ME #chronicillness

[Mary allison @maryisalien]

According Jung's Union of Opposites, the division will get so extreme that humanity collapses before it regenerates.

[Calling Occupants of Interplanetary Craft @PalominoOMG]

I have been posting this woman's videos stolen from Instagram for a while now. Just found her on X. She is awesome, give her a folllow

[EmUprichard @EmUprichard]

Plato Warned Us About ChatGPT (And Told Us What to Do About It) https://t.co/Ql1vT6EUYi

[Canary @TheCanaryUK]

NHS England refuses Palantir review

NHS England has once again confirmed that patients cannot opt out from having their personal data handled by US spy firm Palantir

By @willem_moore_uk
https://t.co/CirXb6fbag

[James Melville 🚜 @JamesMelville]

He drops a whole heap of inconvenient truths on AI data centres. Worth watching.

[Not A Number @myhiddenvalue]

“The World Health Organization” now states on its website:

“Vaccination against COVID-19 can trigger multiple sclerosis through cross-reactive CD4+-T cells that recognize the spike protein of SARS-CoV-2 and myelin peptides.”

In other words: Your own immune system destroys the nerve pathways and then attacks your brain and spinal cord.

[TheGodDonSeo @ConradRica74547]

I had no idea

[Long Covid Scotland 🏴󠁧󠁢󠁳󠁣󠁴󠁿 @LongCovidScot]

In 2025, many of our members told us they'd stopped seeking healthcare.

People with Long Covid are not accessing healthcare - not because they are getting better, but because it’s never met their needs in the first place

#LongCovid #LongCovidScotland

[Dan 🦠➡️🧠🔥 @Dan_Wyke]

Post-exertional malaise is the metabolic inability to recover from physical/cognitive exertion. Most people think this just means tiredness. In reality, at its most severe, each episode of PEM is like a near-death experience that becomes more and more difficult to recover from.

[BladeoftheSun @BladeoftheS]

Wales is about to pass a law allowing them to fire Politicians who lie.

They will be the first country in the world where Politicians aren't allowed to lie.

It's 2026, it's incredible it has taken so long.

[Massimo @Rainmaker1973]

The Kelpies are a pair of 30-meter (100-foot) tall, 300-ton stainless-steel horse-head sculptures located in Falkirk, Scotland

[James Melville 🚜 @JamesMelville]

Road rage. 😂

[Xavier Poussard @XavierPoussard]

🚨Au détour de leur plainte contre @RealCandaceO, les Macron admettent qu'@EmmanuelMacron avait 13 ans – et non pas 17, 15 ou 14, mais bien 13 ans – lorsqu'il a tapé dans l'oeil de "Brigitte". Merci à @f_philippot pour son courage et pour sa persévérance !

[EmUprichard @EmUprichard]

@jonaaronbray I'm loving that all that data work is paying off and your're getting the attention you deserve. Well done for following and staying close to the data!

[Massimo @Rainmaker1973]

This would have been hard to believe if it hadn’t been recorded

[EmUprichard @EmUprichard]

@yoursimmo11 Out of desperation, I tried it. Three weeks I could barely walk.

[Nicolas Hulscher, MPH @NicHulscher]

BREAKING: Largest Human Cancer Study of Ivermectin + Mebendazole Is Now PEER-REVIEWED and PUBLISHED in a MAJOR Cancer Journal

84.4% of cancer patients taking ivermectin + mebendazole for 6 months declared either CANCER DISAPPEARANCE, TUMOR REGRESSION, or CANCER STABILIZATION.

Our study, “Real-world Clinical Outcomes of Ivermectin and Mebendazole in Cancer Patients: Results from a Prospective Observational Cohort,” is now peer-reviewed and published in Anticancer Research—a major international oncology journal of the International Institute of Anticancer Research (IIAR), established in 1995.

The results represent one of the most compelling clinical signals ever documented for repurposed anti-parasitic therapies in oncology.

A diverse population of cancer patients (n=197) was prescribed compounded ivermectin–mebendazole through a U.S. telemedicine platform, with each capsule containing 25 mg ivermectin and 250 mg mebendazole.

Participants were followed for approximately six months using standardized digital surveys assessing cancer outcomes, medication adherence, and tolerability.

At approximately six months post-treatment initiation, we observed an 84.4% Clinical Benefit Ratio (CBR)—meaning more than four out of five patients reported either:
No evidence of disease (32.8%)
Tumor regression (15.6%)
or Cancer stabilization (36.1%)

Importantly, adherence was remarkably high, with 86.9% completing the initial prescription and 66.4% remaining on therapy at six months.

Side effects were predominantly mild and manageable, reported in 25.4% of patients (primarily gastrointestinal), with 93.6% of those experiencing side effects continuing treatment after minor dosing adjustments.

This groundbreaking peer-reviewed publication was made possible through a unique collaboration between The Wellness Company, the McCullough Foundation, and the Chairman of the President’s Cancer Panel—uniting real-world clinical data, frontline medical experience, and epidemiologic expertise to evaluate inexpensive, repurposed therapies with major translational potential.

With these extraordinarily promising results, double-blind, placebo-controlled clinical trials are now required.

In the meantime, many cancer patients are exercising their right to try.

@twc_health @McCulloughFund @IIAR_Journals @P_McCulloughMD @DrHarveyRisch @DrKellyVictory @jathorpmfm @drdrew @PeterGillooly @FosterCoulson

[CECAN @cecanexus]

🌍 CECAN Conference 2026: Global Perspectives on Complex Evaluation
📅 Tue 23 June, 10:00 - 16:00 BST | Online

Live interviews with top international policy evaluation experts from the US & Europe!

Free to attend, book at: https://t.co/41LODwYaWw

#PolicyEvaluation #Complexity